title: [Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
authors.forename: J C
authors.initials: JC
authors.lastname: García Zueco
authors.forename: M
authors.initials: M
authors.lastname: Torres Gómez
authors.forename: L
authors.initials: L
authors.lastname: López Gómez
authors.forename: Y
authors.initials: Y
authors.lastname: Martín Guerrero
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D016609:Neoplasms, Second Primary / Q000175:diagnosis*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012074:Remission Induction; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014750:Vincristine; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate
vernacular_title: Recaída tardía (11 años) en un caso de LAL. Recaída o segunda enfermedad?